Skip to content

Canceled by the investigator. Analgesic effect and drug distribution of erector spinae plane block guided by ultrasound on preoperative puncture localization of pulmonary nodules

Analgesic effect and drug distribution of erector spinae plane block guided by ultrasound on preoperative puncture localization of pulmonary nodules

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063014
Enrollment
Unknown
Registered
2022-08-27
Start date
2022-08-26
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesic effect and drug diffusion of erector spinae plane block guided by ultrasound on preoperative puncture localization of pulmonary nodules

Interventions

Group 1:Patients with anterior/lateral approach for pulmonary nodules: Erector spinae plane block
Group 2:Patients with anterior/lateral approach for pulmonary nodules: Local anesthesia
Group 3:Patient with posterior pulmonary nodule puncture: Erector spinae plane block
Group 4:Patients with pulmonary nodule puncture: Local anesthesia

Sponsors

The Second Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients who plan to receive CT-guided pulmonary nodule puncture positioning under ESP block anesthesia; 2. ASA grade I-II; 3. Age 18-75 years; 4. Agree to participate in this clinical study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with contraindications to iohexol (those allergic to iohexol, patients with thyrotoxicosis, history of epilepsy, liver and kidney dysfunction, etc.); 2. Allergy to ropivacaine or other amide local anesthetics; 3. Body mass index (BMI) >= 30 kg/m2; 4. There are contraindications to regional anesthesia, such as puncture site infection, severe organ dysfunction that cannot tolerate regional block, coagulation dysfunction, etc.; 5. Nerve damage, local sensory loss, etc.; 6. Pregnant and lactating women; 7. Cognitive dysfunction, etc., unable to cooperate with the completion of pain assessment and other assessments; 8. Participate in other clinical medical researchers during the same period.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale (VAS) score;

Secondary

MeasureTime frame
Range of skin block;Complications associated with nerve block;Contrast medium diffusion range;

Countries

China

Contacts

Public ContactZhu jiang

The Second Affiliated Hospital of Soochow University

zhujiangsz@126.com+86 13962153438

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026